Marksans Pharma Ltd. (MARKSANS)
Market Closed
12 Oct, 10:00 PM
MSE XNSE Primary MSE ₹
315. 95
+6.7
+2.1665%
₹
- Market Cap
- P/E Ratio
2% Div Yield
48,852 Volume
- Eps
₹ 309.25
Previous Close Want to track MARKSANS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Marksans Pharma Ltd. (MARKSANS) Statistics
Valuation metrics
Market Cap -
Enterprise value 139.89B
Trailing P/E (ttm) 27.06
Forward P/E -
PEG ratio 0.57
Price/Sales (ttm) 4.41
Price/Book (mrq) 4.58
Enterprise Value/Revenue 4.41
Enterprise Value/EBITDA 18.52
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 133.31K
Average volume (90 days) 231.83K
Price summary
52-Week low 156
52-Week high 350.75
Beta -
50-Day moving average 327.27
200-Day moving average 257.73
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.9
Trailing annual dividend yield 0.0029%
5-Year annual dividend yield -
Payout ratio 0.07
Dividend Date 10 Sep 2026
Ex-Dividend Date 20 Aug 2026
Last split factor 10:1
Last split Date 11 Mar 2008
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.16%
Operating margin 0.19%
Operational effectiveness
Return on assets 0.13%
Return on equity 0.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 69.99
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 11.4
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 21.84
Total debt (mrq) -
Total Debt/Equity (mrq) 0.11
Current ratio (mrq) 5.17%
Book value per share (mrq) 67.36
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
